Humana (HUM) Stock Hits New 52-Week High
Humana (HUM) reached a new 52-week high after reporting Q3 2026 earnings with a smaller loss and raised full-year EPS guidance. Competitors like CVS Health and Elevance Health also saw gains. Clover Health (CLOV) reported Q3 2026 earnings with a slight profit and raised full-year targets.
How this was made
The 30-second read
Why it matters
Both companies delivered better‑than‑expected earnings and raised guidance, prompting immediate stock rallies and suggesting a short‑term bullish bias in the managed‑care sector.
Market read
Earnings beats for two health‑care stocks drive sector‑wide optimism and short‑term price gains.
What to watch
Potential regulatory risk from CMS star‑rating disputes could temper upside.
Background
The article combines post‑earnings price action with detailed Q3 results for Humana and Clover Health, highlighting a rare earnings beat for Humana and a profit turnaround for Clover.
Ticker impact
Humana reported Q3 2026 earnings beating EPS expectations and raised its full-year EPS floor, sending the stock 5.4% higher to a new 52‑week high.
upward pressure as the market prices in the earnings beat and higher EPS floor
EPS beat (+30.3%) and guidance raise are material for a large‑cap insurer, driving immediate price appreciation.
Clover Health posted Q3 2026 results with GAAP net income and raised its full‑year targets, leading to a 7.5% intraday gain.
upward pressure as investors react to the profit turnaround and higher guidance
Turning a loss into net income and raising targets is a strong catalyst for a mid‑cap health‑tech stock.
Market effects
Managed‑care insurers may see broader optimism as earnings beat raises expectations for profit margins.
U.S. healthcare sector gains momentum in the afternoon session.
Limited to U.S. equities; no immediate global macro effect.
Counterpoint
If the earnings beat is already priced in, a pull‑back could occur on profit‑taking.
Key entities
- companyHumana Inc.
U.S. health insurance provider reporting Q3 2026 earnings.
- companyClover Health Investments Corp.
Insurtech firm reporting Q3 2026 earnings and profit turnaround.
